May 2020 in “The journal of investigative dermatology/Journal of investigative dermatology”
This study reported that specific inhibition of the classical complement pathway with BIVV009 prevented C3 deposition along the dermal-epidermal junction in bullous pemphigoid, reflecting its potential efficacy.